What is Scotiabank’s Estimate for Albemarle Q2 Earnings?

Albemarle Corporation (NYSE:ALB) – Equities research analysts at Scotiabank dropped their Q2 2026 earnings per share estimates for Albemarle in a research report issued on Monday, July 27th. Scotiabank analyst B. Isaacson now anticipates that the specialty chemicals company will earn $4.01 per share for the quarter, down from their prior forecast of $4.24. Scotiabank currently has a “Outperform” rating on the stock. The consensus estimate for Albemarle’s current full-year earnings is $12.86 per share. Scotiabank also issued estimates for Albemarle’s FY2026 earnings at $14.76 EPS and FY2027 earnings at $15.56 EPS.

Albemarle (NYSE:ALB) last released its quarterly earnings data on Wednesday, May 6th. The specialty chemicals company reported $2.95 EPS for the quarter, topping the consensus estimate of $1.24 by $1.71. Albemarle had a positive return on equity of 5.22% and a negative net margin of 5.00%.The company had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.34 billion. During the same period last year, the company earned ($0.18) EPS. Albemarle’s revenue for the quarter was up 32.7% on a year-over-year basis.

Other analysts have also issued reports about the stock. Bank of America lifted their price target on shares of Albemarle from $190.00 to $225.00 and gave the stock a “buy” rating in a research note on Tuesday, April 21st. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Albemarle from $210.00 to $250.00 and gave the company a “buy” rating in a research report on Tuesday, May 12th. Zacks Research cut shares of Albemarle from a “strong-buy” rating to a “hold” rating in a report on Monday, July 20th. UBS Group lifted their target price on shares of Albemarle from $230.00 to $264.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. Finally, Oppenheimer boosted their target price on shares of Albemarle from $216.00 to $222.00 and gave the company an “outperform” rating in a research note on Monday, April 13th. Fifteen analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $199.22.

Albemarle Price Performance

ALB opened at $117.87 on Friday. The company’s 50-day simple moving average is $143.95 and its two-hundred day simple moving average is $166.13. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.21 and a current ratio of 2.07. The stock has a market capitalization of $13.90 billion, a P/E ratio of -34.57 and a beta of 1.34. Albemarle has a 52-week low of $64.95 and a 52-week high of $221.00.

Institutional Trading of Albemarle

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ALB. Earnest Partners LLC raised its position in Albemarle by 14.6% in the fourth quarter. Earnest Partners LLC now owns 1,630,394 shares of the specialty chemicals company’s stock worth $230,603,000 after acquiring an additional 207,770 shares during the period. Northern Trust Corp boosted its stake in shares of Albemarle by 1.8% during the 3rd quarter. Northern Trust Corp now owns 1,263,734 shares of the specialty chemicals company’s stock worth $102,464,000 after acquiring an additional 22,856 shares during the last quarter. Goldman Sachs Group Inc. grew its position in shares of Albemarle by 57.7% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,241,106 shares of the specialty chemicals company’s stock valued at $175,542,000 after acquiring an additional 453,881 shares during the period. Norges Bank purchased a new stake in shares of Albemarle in the 4th quarter worth $165,271,000. Finally, Phoenix Financial Ltd. purchased a new stake in shares of Albemarle in the 4th quarter worth $130,415,000. 92.87% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Albemarle

In related news, CEO J Kent Masters sold 16,393 shares of the firm’s stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $183.72, for a total value of $3,011,721.96. Following the transaction, the chief executive officer owned 87,519 shares of the company’s stock, valued at approximately $16,078,990.68. This trade represents a 15.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.42% of the stock is owned by company insiders.

Albemarle Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Friday, September 11th will be paid a $0.41 dividend. This is a boost from Albemarle’s previous quarterly dividend of $0.41. The ex-dividend date is Friday, September 11th. This represents a $1.64 annualized dividend and a dividend yield of 1.4%. Albemarle’s dividend payout ratio (DPR) is currently -48.09%.

About Albemarle

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.